Berridge, M. J. & Irvine, R. F. (1989). Inositol phosphates and cell signalling. Nature 341, 197–205.
Brunello, N., Riva, M., Volterra, A. & Racagni, G. (1986). Biochemical changes in rat brain after acute and chronic administration of fluvoxamine, a selective 5HT uptake blocker: comparison with desmethylimipramine. Advances in Pharmacotherapy 2, 189–196 (Karger: Basel).
Campbell, I. C., McWilliam, J. R. & Adamson, P. (1987). Central adrenergic receptors. Journal of Psychopharmacology 2, 55–66.
Cole, A. J., Saffen, D. W., Baraban, J. M. & Worley, P. F. (1989). Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 340, 474–476.
Coppen, A. (1967). The biochemistry of affective disorders. British Journal of Psychiatry 113, 1237–1264.
Dechant, K. L. & Clissold, S. P. (1991). Paroxetine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 41, 223–253.
Hadcock, J. R. & Malbon, C. C. (1991). Regulating of receptor expression by agonists: transcriptional and post-transcriptional controls. Trends in Neurological Sciences, 14, 242–248.
Kitayama, I., Janson, A. M., Cintra, A., Fuxe, K., Agnati, L. F., Ogren, S.-O., Harfstrand, A., Eneroth, P. & Gustafsson, J.-A. (1988). Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Journal of Neural Transmission 73, 191–203.
Kuhn, R. (1958). The treatment of depressive states with G22355 (imipramine hydrochloride). American Journal of Psychiatry 115, 459–464.
Kupfer, D. J. & Frank, E. (1992). Minimum length of treatment for recovery. In Long-Term Treatment of Depression (ed. Montgomery, S. and Rouillon, F.), pp. 33–52. John Wiley: Chichester.
Leang, P. & Pardee, A. B. (1992). Differential display of enkaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967–971.
Lee, A. S. & Murray, R. M. (1988). The long-term outcome of Maudsley depressives. British Journal of Psychiatry 153, 741–751.
Montgomery, S. & Montgomery, D. B. (1992). Prophylactic treatment in recurrent unipolar depression. In Long-Term Treatment of Depression (ed. Montgomery, S. and Rouillon, F.), pp. 53–79. John Wiley: Chichester.
Morgan, J. I. & Curran, T. (1991). Proto-oncogene transcription factors and epilepsy. Trends in Pharmacological Sciences, 12, 343–349.
Palazzo, M. J. & Meyerowitz, E. M. (1987). A family of lambda phage cDNA cloning vector, lambda SWAJ, allowing the amplification of RNA sequences. Gene 52, 197–202.
Peroutka, S. J. & Schmidt, A. W. (1991). An overview of 5-hydroxytryptamine receptor families. In 5-Hydroxytryptamine in Psychiatry. A Spectrum of Ideas (ed. Sandier, M., Coppen, A. and Harnett, S.) pp. 3–23. Oxford University Press: Oxford.
Schildkraut, J. J. (1965). The catecholamine hypothesis of affective disorders. American Journal of Psychiatry 122, 509–522.
Swerdlow, N. R. & Koob, G. S. (1987). Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of corticostriato- pallido- thalamic function. Behavior and Brain Science 10, 197–245.
Timblin, C., Battey, J. & Kuehl, W. M. (1990). Application for PCR technology to subtractive cDNA cloning: identification of genes expressed specifically in murine plasmocytoma cells. Nucleic Acid Research 18, 1587–1593.
White, T. J., Arnheim, N. & Erlich, H. A. (1989). The polymerase chain reaction. Trends in Genetics 5, 185–189.
Wisden, W., Errington, M. L., Williams, S., Dunnett, S. B., Waters, C., Hitchcock, D., Evans, G., Bliss, T. V. P. & Hunt, S. P. (1990). Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 4, 603–614.